Pharma China (www.pharmachinaonline.com) is the most influential English media and source of business intelligence covering the Chinese pharmaceutical sector. Pharma China caters for the growing needs of the international pharmaceutical industry for up-to-date and insightful information and intelligence on China’s burgeoning but increasingly complex healthcare marketplace, and is subscribed by most MNC pharma companies, leading CROs, investment banks, consulting firms active in China as well as relevant industry associations and government agencies.

Note: To view full text of free articles, you need to register as a basic member first and then log in. To view premium articles, you need to subscribe to Pharma China as a premium member. For more information or subscription, please contact info@pharmachinaonline.com. If you wish to unsubscribe from this e-Alert, please reply this e-mail with "Remove" in the subject line.
Editor´s Picks
China's Biopharma Rise: Opportunities and Threats(7/10/2018 )  (Premium)
Industry News
Merck and Xian Janssen to Co-launch Type 2 Diabetes Drug in China(7/12/2018 )  (Premium)
Ping An Reportedly to Make Rival Offer for China Biologic(7/10/2018 )  (free)
Transgene Swaps JV Ownership for Stake in Tasly Biopharma(7/10/2018 )  (Premium)
iBio Establishes Strategic Commercial Relationship with CC-Pharming(7/10/2018 )  (Premium)
China Agrees to Slash Import Duties on Indian Medicines(7/10/2018 )  (Premium)
Tocagen Closes Licensing Deal with ApolloBio for Immunotherapy Toca 511 & Toca FC in Greater China(7/10/2018 )  (free)
Regulatory News
CNDA Solicits Comments on GMP for Clinical Trial Drugs(7/13/2018 )  (Premium)
CDE Solicits Comments on Technical Requirements for Topical Dermatological Generics(7/11/2018 )  (Premium)
CNDA Issues Technical Guidelines for Acceptance of Foreign Drug Clinical Trial Data (with Summary)(7/10/2018 )  (Premium)
U.S. FDA and CNDA Officials Meet to Exchange Anticancer Regulatory Experience(7/10/2018 )  (Premium)
General Health
SMIA Mulls Tender for Anticancers as It Plans New Mechanism for Updating NRDL(7/13/2018 )  (Premium)
NHC Reports on Growing Sector of Private Healthcare Providers in China(7/13/2018 )  (Premium)
Shanghai Unveils New Open Policy Measures, Benefiting Pharma/MedTech Industries(7/11/2018 )  (Premium)
Updated - NHC Issues Drug Prescription Review Guidelines of Medical Institutions (with Summary)(7/10/2018 )  (Premium)
Product/R&D News
Sirona Biochem Announces CNDA Approval of SGLT2 Inhibitor for Phase I Trial(7/12/2018 )  (Premium)
CStone's PD-1 Inhibitor CS1003 Gets Clinical Trial Approval in China(7/12/2018 )  (Premium)
People in the News
Recent Executive Moves(7/13/2018 )  (Premium)
© Wicon International GroupˇˇSupport by: www.heightow.com Home | Site map | Contact Us | Links